Market Trends– category –
-
CoSara PCR MTB: India regulatory submission and 2026 launch timeline
BioSpace (PR Newswire company press release) USA Overview CoSara Diagnostics has completed clinical studies and submitted its point-of-care tuberculosis (TB) test to India's CDSCO for regulatory clearance. The test demonstrated 97.3% sen... -
Masimo smartSET: FDA clearance for AFib and OIRD detection
Clinical Trial Vanguard USA Overview Masimo has received FDA 510(k) clearance for smartSET, a pulse oximetry tool capable of real-time detection of atrial fibrillation (AFib) and opioid-induced respiratory depression (OIRD). The AFib det... -
Libre DUO 10 Day system: FDA-authorized dual glucose-ketone sensor
FreeStyle Libre US (Abbott) USA Overview Abbott's Libre DUO 10 Day system is the first dual glucose and ketone sensor to receive FDA authorization. The device enables simultaneous monitoring of both biomarkers from a single sensor to imp... -
Google Health and Fitbit: Hardware Updates and Ecosystem Roadmap
Google USA Overview Google is expanding its health ecosystem with the introduction of the Fitbit Edge and Fitbit Air wearables, alongside the "Health Guardian" monitoring suite. The update integrates contextual reasoning to increase acti... -
Lab-on-a-Chip 2026: 30-minute POC diagnostics assay explained
SelectBIO Conferences Unknown Overview The upcoming Lab-on-a-Chip and Microfluidics World Congress 2026 will feature a presentation on a groundbreaking one-pot, room-temperature assay workflow for point-of-care (POC) rapid diagnostics. T... -
EASD 2026 Study Reveals Continuous Glucose Monitoring Slashes Type 2 Diabetes Mortality by 44% in Real-World Evidence
Next Move Strategy Consulting USA Overview A groundbreaking study presented at EASD 2026 demonstrated that continuous glucose monitoring (CGM) use is associated with a 44% lower all-cause mortality risk at 12 months in adults with Type 2... -
Biolinq Shine Receives FDA 510(K) Clearance as First Needle-Free Wearable Biosensor for Glucose, Sleep, and Activity Tracking Without Prescription
Beyond Type 1 USA Overview The FDA has granted 510(K) clearance to Biolinq Shine, making it the first needle-free wearable biosensor capable of tracking glucose, sleep, and activity. This prescription-free device significantly expands ac... -
Heriot-Watt University: 6-hour sepsis pathogen ID timeline
Pathology In Practice UK Overview An international project led by Heriot-Watt University is advancing a rapid blood-based DNA sequencing approach (iSEP-SEQ) for faster sepsis pathogen identification. This microfluidic engineering techniq... -
AI Revolutionizes ABA Data Collection and Management with Wearable Sensors and Audio Analysis for Predictive Behavioral Intervention
Artemis ABA USA Overview Artemis ABA highlights innovative AI applications for ABA (Applied Behavior Analysis) data collection, including automated interpretation via computer vision, machine learning predictions from wearable sensors, a... -
Brazilian Deeptech Doroth Raises US$4.5 Million to Build Latin America’s First Microfluidic Chip Plant, Targeting 4 Million Annual Production
Latam Republic Brazil Overview Brazilian deeptech company Doroth has raised US$4.51 million to construct Latin America's first microfluidic chip manufacturing facility, aiming for an annual capacity of up to 4 million chips. This strateg...
12